BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10218670)

  • 1. Expression of p-27 (kip1) in nevi and melanomas.
    Morgan MB; Cowper SE
    Am J Dermatopathol; 1999 Apr; 21(2):121-4. PubMed ID: 10218670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of activated Akt in benign nevi, Spitz nevi and melanomas.
    Kantrow SM; Boyd AS; Ellis DL; Nanney LB; Richmond A; Shyr Y; Robbins JB
    J Cutan Pathol; 2007 Aug; 34(8):593-6. PubMed ID: 17640227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-fos protein expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Bergman R; Kerner H; Manov L; Friedman-Birnbaum R
    Am J Dermatopathol; 1998 Jun; 20(3):262-5. PubMed ID: 9650699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
    Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
    Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of p16 in desmoplastic melanoma.
    Blokhin E; Pulitzer M; Busam KJ
    J Cutan Pathol; 2013 Sep; 40(9):796-800. PubMed ID: 23808580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spitz's nevi with halo reaction: a histopathologic study of 17 cases.
    Harvell JD; Meehan SA; LeBoit PE
    J Cutan Pathol; 1997 Nov; 24(10):611-9. PubMed ID: 9449488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.